(RTTNews) - LG Corp. (003550.KS, 003555.KS), a South Korean electronics, chemicals, telecommunications, and household appliances company, on Thursday reported lower net income in the first quarter of 2026 compared with the previous year.
(RTTNews) - LG Corp. (003550.KS, 003555.KS), a South Korean electronics, chemicals, telecommunications, and household appliances company, on Thursday reported lower net income in the first quarter of 2026 compared with the previous year.
A.P. Møller - Mærsk A/S press release ( AMKBY ): Q1 GAAP EPS of $4.00. Revenue of $12.97B (-2.6% Y/Y). More on A.P. Møller - Mærsk A/S Oil prices slip as military escorts ease Hormuz supply fears Maersk-operated ship escorted by U.S. military through Strait of Hormuz Seeking Alpha’s Quant Rating on A.P. Møller - Mærsk A/S Historical earnings data for A.P. Møller - Mærsk A/S Dividend scorecard for ...
A.P. Møller - Mærsk A/S press release ( AMKBY ): Q1 GAAP EPS of $4.00. Revenue of $12.97B (-2.6% Y/Y). More on A.P. Møller - Mærsk A/S Oil prices slip as military escorts ease Hormuz supply fears Maersk-operated ship escorted by U.S. military through Strait of Hormuz Seeking Alpha’s Quant Rating on A.P. Møller - Mærsk A/S Historical earnings data for A.P. Møller - Mærsk A/S Dividend scorecard for A.P. Møller - Mærsk A/S
格隆汇5月7日｜据中国贸易救济信息网消息，2026年5月5日，欧盟委员会发布公告，对原产于中国的己二酸（Adipic Acid）作出反倾销终裁，裁定重庆华峰化工有限公司（Chongqing Huafon Chemical Co., Ltd.）反倾销税为29.1%、唐山中浩化工有限公司（Tangshan Zhonghao Chemical Co., Ltd.）反倾销税为42.3%、其他合作企业反倾销...
格隆汇5月7日｜据中国贸易救济信息网消息，2026年5月5日，欧盟委员会发布公告，对原产于中国的己二酸（Adipic Acid）作出反倾销终裁，裁定重庆华峰化工有限公司（Chongqing Huafon Chemical Co., Ltd.）反倾销税为29.1%、唐山中浩化工有限公司（Tangshan Zhonghao Chemical Co., Ltd.）反倾销税为42.3%、其他合作企业反倾销税为31.5%、中国其他生产商/出口商反倾销税为42.3%。涉案产品的欧盟CN（Combined Nomenclature）编码为ex 2917 12 00（TARIC编码为2917 12 00 10）。本案倾销调查期为2024年1月1日至2024年12月31日，损害调查期为2021年1月1日至倾销调查期结束。公告自发布次日起生效。2025年3月14日，对原产于中国的己二酸发起反倾销调查。2025年11月13日，欧盟委员会对原产于中国的己二酸作出反倾销初裁。
ninitta/iStock via Getty Images Shares of Primerica ( PRI ) have been a modest performer over the past year, gaining just 5%. While it has delivered steady results, its focus on middle-income consumers has led to pressure and concern as affordability pressures may be forcing some households to defer larger financial transactions. While Q1 showcased some of these pressures, earnings were resilient....
ninitta/iStock via Getty Images Shares of Primerica ( PRI ) have been a modest performer over the past year, gaining just 5%. While it has delivered steady results, its focus on middle-income consumers has led to pressure and concern as affordability pressures may be forcing some households to defer larger financial transactions. While Q1 showcased some of these pressures, earnings were resilient. I last covered Primerica in January , rating the stock a “buy,” and since then, its 6% rally has been similar to the market. With updated financials, now is a good time to revisit PRI. Seeking Alpha Affordability Pressures Limit Sales In the company 's first quarter, Primerica earned $5.96, which beat estimates by $0.48 as operating revenue grew 9% to $872 million. EPS was up 19% from last year, reflecting the benefit of buybacks and improved margins. With an average household income of $85,000, PRI 's customer base is largely middle class and has confronted meaningful affordability challenges over the past few years. The more difficult selling environment has led to a decline in representatives, with its licensed sales force down 2% to 150k, and recruits are down 17% from last year. Buying a term life policy, Primerica 's focus, is a relatively discretionary activity and can be deferred during periods of stress. This is happening to an extent with policies issued declining 14% to 74k. As a result, productivity is down to 0.16 sales/month/rep from 0.19 last year. That weaker sales environment is what has caused some attrition in its sales force. Thanks to slightly higher policy values, the face value of sales was down 10% to $26 billion. Its Business is Fee-Based and Resilient While sales were down sharply, revenue still grew 1% to $465 million, and operating income jumped 6% to $155 million. Adjusted premiums were up 4%, reflecting the sales activity of the past year. Its benefit and claims ratio improved 90bps to 57.3%. Term life policies are straightforward, and the com...